Zhongda Hospital

This early-phase trial tests whether adding two drugs (darolutamide and homoharringtonine) to standard chemo and hormone therapy can more thoroughly clear high-risk prostate cancer before surgery. About 94 men will receive the combo for 7 weeks, then have their prostate removed t…

This study will test a type of endoscopic surgery to remove certain stomach tumors that grow outward from the stomach wall. The goal is to see if this less invasive approach can completely remove the tumors and prevent them from coming back. The study will involve 20 participants…

This study tests whether adding the heart medication propranolol to standard hormone therapy before prostate removal can improve outcomes for high-risk prostate cancer patients. About 30 men will receive the combination treatment for several weeks before surgery. The goal is to s…

This study looks at whether roxadustat, a drug for anemia in chronic kidney disease, can also help people with heart failure. Researchers will review medical records of 200 patients who took roxadustat for at least a year. They will check heart function, symptoms, and major event…

This study tests whether adding a nerve-zapping procedure called endovascular denervation (EDN) to standard liver cancer treatments (TACE/HAIC and immune-targeted drugs) can improve outcomes for people with advanced liver cancer that has spread to the portal vein and stopped resp…

This study looks at how changes in blood pressure during the start of anesthesia and throughout surgery may affect the risk of kidney injury after non-cardiac surgery. Researchers will review medical records from 5,000 adults to find patterns. The goal is to better understand how…